Duke Capital Boosts Investment in Integrum for Strategic Acquisition

The latest announcement is out from Duke Capital ( (GB:DUKE) ).

Duke Capital Limited has announced a follow-on investment of £6.0 million into Integrum Group Holdings Limited to facilitate its acquisition of Swanborough House, a care home specializing in acquired brain injury rehabilitation. This investment increases Duke’s total credit financing in Integrum to £20.5 million and supports Integrum’s buy-and-build strategy, enhancing its portfolio in the elderly care sector. The acquisition will expand Integrum’s reach, catering to over 300 service users and employing over 550 staff, further solidifying its position in the market.

The most recent analyst rating on (GB:DUKE) stock is a Buy with a £41.00 price target. To see the full list of analyst forecasts on Duke Capital stock, see the GB:DUKE Stock Forecast page.

Spark’s Take on GB:DUKE Stock

According to Spark, TipRanks’ AI Analyst, GB:DUKE is a Neutral.

Duke Capital’s overall stock score is primarily influenced by its stable financial foundation and attractive dividend yield. However, challenges in revenue and profitability, coupled with bearish technical indicators, weigh on the score. The lack of earnings call data and corporate events limits additional insights.

To see Spark’s full report on GB:DUKE stock, click here.

More about Duke Capital

Duke Capital is a leading provider of hybrid capital solutions for SME business owners in Europe and North America, combining features of both equity and debt. Since 2017, Duke has offered long-term financing that mitigates refinancing risks and aligns returns with business success. The company focuses on capital preservation, attractive dividend yield, and providing upside upon exits, and is listed on the AIM market under the ticker DUKE, headquartered in Guernsey.

Average Trading Volume: 597,032

Technical Sentiment Signal: Buy

For an in-depth examination of DUKE stock, go to TipRanks’ Overview page.